|
May 15
|
Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss
|
|
May 14
|
Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week
|
|
May 9
|
Veru Inc (VERU) Q2 2024 Earnings Call Transcript Highlights: Strategic Focus and Financial Recovery
|
|
May 8
|
Veru Inc. (VERU) Fiscal 2024 Q2 Earnings: Clinical Advances Amid Financial Strains
|
|
May 8
|
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
|
|
May 2
|
Veru to Present at the GLP-1 Based Therapeutics Summit
|
|
May 1
|
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
|
|
Apr 30
|
Veru Inc. (VERU) Just Flashed Golden Cross Signal: Do You Buy?
|
|
Apr 30
|
Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
|
|
Apr 25
|
Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11
|
|
Apr 17
|
What Makes Veru (VERU) a New Buy Stock
|
|
Apr 1
|
Veru Announces Date of 2024 Annual Meeting of Shareholders
|
|
Mar 22
|
Veru Reschedules Annual Meeting of Shareholders
|
|
Mar 12
|
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
|
|
Feb 20
|
Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss
|
|
Dec 19
|
Veru to Host Investor Call on January 4th, 2024 to Discuss Recent Financing and Strategy to Prioritize the Development of Enobosarm as a Combination Treatment to Prevent Muscle Loss and Augment Fat Loss Associated with Weight Loss GLP-1 Drugs
|
|
Dec 18
|
The Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 29%
|
|
Dec 14
|
Veru Announces Pricing of Public Offering of Common Stock
|
|
Dec 13
|
Veru Announces Proposed Public Offering of Common Stock
|
|
Nov 8
|
Verano Holdings Corp. (VRNOF) Reports Q3 Loss, Lags Revenue Estimates
|